gainzlabuk.com
No products in the cart.
Return To Shopgainzlabuk.com
No products in the cart.
Return To ShopAzicip 500 mg, produced by Cipla, is a well-regarded medication that has garnered attention not only in the treatment of bacterial infections but also for its potential utility in sports pharmacology. If you’re considering purchasing Azicip 500 mg, buying from us ensures you receive the best price with high-quality assurance. Our platform provides competitive rates, ensuring affordability without compromising authenticity. Additionally, we prioritize secure transactions and swift delivery. Trust in our reputation to supply genuine products is paramount. With customer-focused service and a commitment to reliability, you can buy Azicip with peace of mind.
Azicip, with its active ingredient Azithromycin, is a macrolide antibiotic that plays a crucial role in fighting various bacterial infections. Each 500 mg tablet contains Azithromycin and a range of inert ingredients that aid in maximizing bioavailability. The unique formulation contributes to its longer half-life, allowing it to maintain effective levels in the body over extended periods. Azicip is particularly noted for its broad spectrum of activity against multiple strains of bacteria, making it a versatile choice for both therapeutic and potential ergogenic uses in sports contexts.
The activity of Azicip is robust, inhibiting bacterial protein synthesis by binding to the 50S ribosomal subunit, ultimately leading to the eradication of pathogens. This mechanism not only aids in treating infections effectively but also plays a role in mitigating inflammation, which can assist in recovery processes post-exertion.
Understanding the mechanism of action of Azicip provides insight into its biological effects and potential applications in sports pharmacology. After administration, Azithromycin is rapidly absorbed into the bloodstream and distributes widely in tissues, including lung, skin, and soft tissues. Its ability to penetrate cellular membranes results in higher concentration levels within infected cells.
Azicip works by inhibiting bacterial protein synthesis, effectively disrupting their ability to grow and multiply. This action leads to a decline in infection-related inflammation, allowing athletes to recover more efficiently from physical stress or injuries caused by microbial agents.
The anti-inflammatory properties associated with Azithromycin might also benefit athletes by reducing systemic inflammation, promoting a more favorable environment for recovery and performance enhancement.
Several studies have indicated that Azicip may offer performance-enhancing benefits, particularly in the context of recovery from illness or injury. Athletes frequently face the risk of infections that can hinder their training regimens, and using Azicip as part of a holistic recovery strategy may help mitigate these issues.
Research has shown that maintaining health and reducing downtime is critical for optimal athletic performance. Athletes using Azicip during an illness can often resume their training with less interruption, thus maintaining their performance levels. In addition, the anti-inflammatory effects can lead to decreased muscle soreness and improved recovery times, offering a significant advantage during competitive seasons.
While public attention often highlights synthetic performance enhancers, Azicip’s capabilities underscore the importance of managing health and recovery as part of an athlete’s training regimen.
Safety is paramount when considering any pharmacological intervention. Azicip is generally well-tolerated; however, it is essential to be aware of potential side effects such as gastrointestinal disturbances, dizziness, or allergic reactions. Individuals with a history of hypersensitivity to Azithromycin or any macrolide antibiotics should avoid using this product.
Moreover, it is advisable for athletes to consult with healthcare professionals before incorporating Azicip into their regimen, particularly if they have pre-existing medical conditions, are pregnant, or are taking other medications that may interact adversely.
The following recommendations can help maximize benefits and minimize risks:
In summary, Azicip 500 mg by Cipla serves as both an effective antibiotic and a facilitator of improved recovery and overall performance for athletes.
| Active substance | Azithromycin |
|---|---|
| Water Retention | No significant effect on water retention |
| Hepatotoxicity | Rare, usually mild and reversible |
| Lab Test | No specific lab tests required for monitoring |
| Strength | 500mg |
| Also known as | Zithromax |
| Blood pressure | No significant effects on blood pressure |
| Trade name | Zithromax, Azithrocin |
| Storage conditions | Store at room temperature away from moisture and heat |
| Formula | C38H72N2O12 |
| Substance class | Macrolide antibiotic |
| Main action | Bacteriostatic (inhibits bacterial protein synthesis) |
| Half-life | 68 hours |
| Dosage (medical) | Typically 500 mg on the first day followed by 250 mg daily for 4 days or as directed by a physician |
| Dosage (sports) | Not applicable |
| Effects | Effective against a variety of bacterial infections, including respiratory infections, skin infections, ear infections, and sexually transmitted infections |
| Side effects | Nausea, vomiting, diarrhea, abdominal pain, and rarely, allergic reactions |
| Use in sports | Not typically used in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 3 tabs/blister |
Reviews
There are no reviews yet.